Investigating the effect of sucralfate 15% gel in decreasing of bedsore degree I & II

INTERVENTION: Intervention 1: There are 30 case with bedsore rank 1 or 2 in this study that will receive Sucralfate 15% gel during 7 days. Then the ulcer will observe for size, color and discharge. Intervention 2: There are 30 control with bedsore rank 1 or 2 in this study that will receive placebo gel during 7 days. Then the ulcer will observe for size, color and discharge. Placebo There are 30 case with bedsore rank 1 or 2 in this study that will receive Sucralfate 15% gel during 7 days. Then the ulcer will observe for size, color and discharge. There are 30 control with bedsore rank 1 or 2 in this study that will receive placebo gel during 7 days. Then the ulcer will observe for size, color and discharge. Treatment ‐ Drugs CONDITION: Bedsore. ; Decubitus ulcer and pressure area Decubitus ulcer and pressure area PRIMARY OUTCOME: Discharge. Timepoint: 7 days. Method of measurement: drainage. Ulcer color. Timepoint: 7 days. Method of measurement: Observation. Ulcer size. Timepoint: 7 days. Method of measurement: ruler. INCLUSION CRITERIA: INCLUSION CRITERIA: All of patients that have bedsore I &II degree; base on American Society of Anesthesiology protocols Exclusion criteria: Adverse reaction to the product; Or the bedsore degree increase to III and IV